Skip to main content

. 1982 Jun 5;284(6330):1672–1673. doi: 10.1136/bmj.284.6330.1672

"Scalded mouth" caused by angiotensin-converting-enzyme inhibitors.

P H Vlasses, H H Rotmensch, R K Ferguson, S L Sheaffer

PMCID: PMC1498640 PMID: 6282382

1672

Images in this article

p1673-a
on p.1673

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Ferguson R. K., Vlasses P. H. Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril. Am Heart J. 1981 May;101(5):650–656. doi: 10.1016/0002-8703(81)90233-7. [DOI] [PubMed] [Google Scholar]
Gavras H., Biollaz J., Waeber B., Brunner H. R., Gavras I., Davies R. O. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421". Lancet. 1981 Sep 12;2(8246):543–547. doi: 10.1016/s0140-6736(81)90937-5. [DOI] [PubMed] [Google Scholar]
Nicholls M. G., Maslowski A. H., Ikram H., Espiner E. A. Ulceration of the tongue: a complication of captopril therapy. Ann Intern Med. 1981 May;94(5):659–659. doi: 10.7326/0003-4819-94-5-659. [DOI] [PubMed] [Google Scholar]
Seedat Y. K. Aphthous ulcers of mouth from captopril. Lancet. 1979 Dec 15;2(8155):1297–1298. doi: 10.1016/s0140-6736(79)92304-3. [DOI] [PubMed] [Google Scholar]
Vlasses P. H., Ferguson R. K. Temporary ageusia related to captopril. Lancet. 1979 Sep 8;2(8141):526–526. doi: 10.1016/s0140-6736(79)91579-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES